Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTB101 Prophylaxis for COVID-19 in Nursing Home Residents
NCT04409327Phase 2Terminated
- Sponsor
- resTORbio
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dactolisib in coronavirus disease 2019 (COVID-19), sponsored by resTORbio. Started Jul 2020; status: terminated.
02
Drugs
dactolisib
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04409327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04409327.